Monday, 7 June 2010

Study assessing a new formulation of Copaxone(R) brings positive results

From the MSRC Website:

Teva Pharmaceutical Industries Ltd. announced positive results from a study assessing a new lower-volume injection of Copaxone(R) (glatiramer acetate) containing the currently approved dose in half the injection volume. http://www.msrc.co.uk/index.cfm/fuseaction/show/pageid/2479